AA

Amita Agarwal

Active Director Director DIN 09602048
DIN 09602048 First appointment May 2022 Primary industry Information Technology
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since May 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Amita Agarwal

Data last updated:

Amita Agarwal is a Director at Cuedevlabs Private Limited (since 2022) and Director at Avida Pharmaceuticals Private Limited (since 2022). The companies operate in Information Technology and Non-Profit Organizations.

DIN 09602048
Primary Designation Director
Industry Information Technology
First Appointment 11 May 2022
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Cuedevlabs Private Limited U72900UP2022PTC174997
Director13 Dec 20222022Active
Director11 May 20222022Active

Board colleagues of Amita Agarwal

Directorship timeline

Open interactive timeline →
Avida Pharmaceuticals Private Limited
Cuedevlabs Private Limited
Premium access

Shareholding and investment profile for Amita Agarwal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Amita Agarwal

Amita Agarwal currently holds 2 directorships: Cuedevlabs Private Limited (Director, since 13 Dec 2022); Avida Pharmaceuticals Private Limited (Director, since 11 May 2022).

Amita Agarwal was first appointed on 11 May 2022 as Director at Avida Pharmaceuticals Private Limited.

The current boards of Amita Agarwal's companies include Arshita Agarwal (Cuedevlabs Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available